Researchers estimate that the economic cost of Long COVID in the US is $3.7 trillion, which is comparable to the cost of the Great Recession.
It is reckless for governments to ignore preventing and treating COVID and Long COVID.
The Economic Cost of Long COVID: An Update - David Cutler
2022, Paper: "In a 2020 JAMA Viewpoint, Lawrence Summers and I guessed at the possible economic costs of long COVID.1 At the time, we thought the cost might be $2.6 trillion. With more data, that estimate can be updated. I do so here. Background Many survivors of SARS-CoV-2 infection suffer “long COVID,” formally termed PostAcute Sequelae of SARS-CoV-2 infection (PASC). Data suggest that 22-38% of people with COVID will have at least one symptom 12 weeks after initial onset, and 12-17% will have three or more symptoms.



